CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
46 hedge funds and large institutions have $78.2M invested in Carisma Therapeutics in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
40% more call options, than puts
Call options by funds: $1.23M | Put options by funds: $878K
1.4% more ownership
Funds ownership: 1.22% → 2.62% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
46
Holding in Top 10
1
Calls
$1.23M
Puts
$878K
Top Buyers
| 1 | +$14.7M | |
| 2 | +$13.3M | |
| 3 | +$7.25M | |
| 4 |
KCM
Kingdon Capital Management
New York
|
+$6.32M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$5.12M |
Top Sellers
| 1 | -$1.67M | |
| 2 | -$1.29M | |
| 3 | -$258K | |
| 4 |
Squarepoint
New York
|
-$40K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$36K |